Brief: Opus Genetics Announces $25 Million Private Placement
13/02/2026 12:41
Feb 13 (Reuters) - Opus Genetics Inc IRD.O: OPUS GENETICS ANNOUNCES $25 MILLION PRIVATE PLACEMENT OPUS GENETICS INC - TO USE NET PROCEEDS TO ADVANCE ITS GENE THERAPY CLINICAL PROGRAMS OPUS GENETICS INC - EXPECTS ITS YEAR-END 2025 PRO FORMA CASH BALANCE OF $70 MILLION WILL FUND OPERATIONS INTO FIRST HALF OF 2028 OPUS GENETICS INC: FINANCING IS BEING LED BY ADAGE CAPITAL MANAGEMENT, WITH PARTICIPATION BY TRAILS EDGE CAPITAL PARTNERS AND MARSHALL WACE Source text: ID:nGNX30prt2 Further company coverage: IRD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Opus Genetics
See all newsUS RESEARCH ROUNDUP-Affiliated Managers Group, Goldman Sachs, Vaxcyte
Health Rounds: Experimental eye drops ease night vision problems for drivers
U.S. STOCKS ON THE MOVE-Apple, Omnicom, Jersey Mike's Subs
U.S. STOCKS ON THE MOVE-Airbnb, Lyft, Korn Ferry
Opus Genetics hits 5-year high on positive early- to mid-stage eye disease gene therapy data